Loading...

Inspire Medical Systems

NYSE:INSP
Snowflake Description

Excellent balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
INSP
NYSE
$1B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). The last earnings update was 50 days ago. More info.


Add to Portfolio Compare Print
INSP Share Price and Events
7 Day Returns
-1.6%
NYSE:INSP
3.7%
US Healthcare Services
0.4%
US Market
1 Year Returns
-
NYSE:INSP
26.1%
US Healthcare Services
6.8%
US Market
INSP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Inspire Medical Systems (INSP) -1.6% -5.3% 2.2% - - -
US Healthcare Services 3.7% 3.4% 11.7% 26.1% 59.7% 44.7%
US Market 0.4% 2.6% 11% 6.8% 38.1% 45.7%
1 Year Return vs Industry and Market
  • No trading data on INSP.
  • No trading data on INSP.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Inspire Medical Systems undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Inspire Medical Systems. This is due to cash flow or dividend data being unavailable. The share price is $54.76.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Inspire Medical Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Inspire Medical Systems's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:INSP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-1.50
NYSE:INSP Share Price ** NYSE (2019-04-16) in USD $54.76
United States of America Healthcare Services Industry PE Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 80.75x
United States of America Market PE Ratio Median Figure of 3,072 Publicly-Listed Companies 18.08x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Inspire Medical Systems.

NYSE:INSP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:INSP Share Price ÷ EPS (both in USD)

= 54.76 ÷ -1.50

-36.58x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Inspire Medical Systems is loss making, we can't compare its value to the US Healthcare Services industry average.
  • Inspire Medical Systems is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Inspire Medical Systems's expected growth come at a high price?
Raw Data
NYSE:INSP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -36.58x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts
7.2%per year
United States of America Healthcare Services Industry PEG Ratio Median Figure of 13 Publicly-Listed Healthcare Services Companies 2.76x
United States of America Market PEG Ratio Median Figure of 2,107 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Inspire Medical Systems, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Inspire Medical Systems's assets?
Raw Data
NYSE:INSP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $7.01
NYSE:INSP Share Price * NYSE (2019-04-16) in USD $54.76
United States of America Healthcare Services Industry PB Ratio Median Figure of 34 Publicly-Listed Healthcare Services Companies 4.23x
United States of America Market PB Ratio Median Figure of 5,176 Publicly-Listed Companies 1.91x
NYSE:INSP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:INSP Share Price ÷ Book Value per Share (both in USD)

= 54.76 ÷ 7.01

7.81x

* Primary Listing of Inspire Medical Systems.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Inspire Medical Systems is overvalued based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess Inspire Medical Systems's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Inspire Medical Systems has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Inspire Medical Systems expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
7.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Inspire Medical Systems expected to grow at an attractive rate?
  • Unable to compare Inspire Medical Systems's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Inspire Medical Systems's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.
  • Inspire Medical Systems's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:INSP Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:INSP Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts 7.2%
NYSE:INSP Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 7 Analysts 26.3%
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 22.4%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 11.5%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:INSP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:INSP Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 12
2022-12-31 157 0 -16 3
2021-12-31 128 -17 -22 4
2020-12-31 96 -25 -33 7
2019-12-31 70 -36 -37 7
NYSE:INSP Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 51 -19 -22
2018-09-30 44 -19 -21
2018-06-30 38 -19 -21
2018-03-31 33 -17 -20
2017-12-31 29 -16 -18
2016-12-31 16 -18 -19

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Inspire Medical Systems is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Inspire Medical Systems's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:INSP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below

All data from Inspire Medical Systems Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:INSP Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31 -0.39 -0.04 -0.57 3.00
2021-12-31 -0.85 -0.65 -0.99 4.00
2020-12-31 -1.35 -1.06 -1.99 6.00
2019-12-31 -1.57 -1.24 -1.74 6.00
NYSE:INSP Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -1.50
2018-09-30 -2.26
2018-06-30 -4.77
2018-03-31 -16.13
2017-12-31 -14.88
2016-12-31 -16.90

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Inspire Medical Systems will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Inspire Medical Systems's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Inspire Medical Systems has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Inspire Medical Systems performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Inspire Medical Systems's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Inspire Medical Systems does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Inspire Medical Systems's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Inspire Medical Systems's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Inspire Medical Systems's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Inspire Medical Systems Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:INSP Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 50.59 -21.83 53.53 7.39
2018-09-30 43.99 -21.30 47.66 6.92
2018-06-30 38.21 -20.63 42.37 6.32
2018-03-31 33.31 -19.53 36.94 6.33
2017-12-31 28.57 -17.51 32.36 6.19
2016-12-31 16.43 -18.53 22.68 7.09
2015-12-31 8.01 -21.34 17.92 7.08

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Inspire Medical Systems has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Inspire Medical Systems has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Inspire Medical Systems improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Inspire Medical Systems's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Inspire Medical Systems has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Inspire Medical Systems's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Inspire Medical Systems's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Inspire Medical Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Inspire Medical Systems's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Inspire Medical Systems's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Inspire Medical Systems Company Filings, last reported 3 months ago.

NYSE:INSP Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 164.00 24.93 188.21
2018-09-30 98.31 24.81 120.43
2018-06-30 102.58 24.70 123.96
2018-03-31 -3.96 24.57 17.90
2017-12-31 1.48 16.46 16.14
2016-12-31 -6.56 15.69 6.69
2015-12-31
  • Inspire Medical Systems's level of debt (15.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Inspire Medical Systems's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Inspire Medical Systems has sufficient cash runway for more than 3 years based on current free cash flow.
  • Inspire Medical Systems has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -5.1% each year.
X
Financial health checks
We assess Inspire Medical Systems's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Inspire Medical Systems has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Inspire Medical Systems's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Inspire Medical Systems dividends. Estimated to be 0% next year.
If you bought $2,000 of Inspire Medical Systems shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Inspire Medical Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Inspire Medical Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:INSP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2008 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:INSP Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31 0.00 1.00
2021-12-31 0.00 1.00
2020-12-31 0.00 2.00
2019-12-31 0.00 2.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Inspire Medical Systems has not reported any payouts.
  • Unable to verify if Inspire Medical Systems's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Inspire Medical Systems's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Inspire Medical Systems has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Inspire Medical Systems's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Inspire Medical Systems's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Inspire Medical Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Inspire Medical Systems has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Inspire Medical Systems's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Timothy Herbert
COMPENSATION $3,260,769
AGE 55
TENURE AS CEO 11.4 years
CEO Bio

Mr. Timothy P. Herbert has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007. He is the Founder of Inspire Medical Systems, Inc. Mr. Herbert has over 25 years of experience in new business development including over 11 years at Medtronic and 7 years at Inspire Medical Systems. He has held management positions in product development, clinical research, regulatory, sales, marketing, and healthcare reimbursement. He has been part of the Inspire business since 1996, assuming management of the venture in 1998. With extensive experience in venture development, as well as his detailed knowledge of the Inspire system, OSA disease state, and the sleep diagnostic and therapeutic market, he is well positioned to lead the Inspire organization. Mr. Herbert has a B.S. in Electrical Engineering from North Dakota State University and an M.B.A. from the University of St. Thomas.

CEO Compensation
  • Timothy's compensation has increased whilst company is loss making.
  • Timothy's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Inspire Medical Systems management team in years:

7.6
Average Tenure
52
Average Age
  • The average tenure for the Inspire Medical Systems management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Timothy Herbert

TITLE
CEO, President & Director
COMPENSATION
$3M
AGE
55
TENURE
11.4 yrs

Rick Buchholz

TITLE
Chief Financial Officer
COMPENSATION
$1M
AGE
50
TENURE
4.9 yrs

Randy Ban

TITLE
Senior Vice President of Global Sales & Marketing
COMPENSATION
$1M
AGE
53
TENURE
10.3 yrs

John Rondoni

TITLE
Vice President of Product Development

Steven Jandrich

TITLE
Chief Compliance Officer & VP of Human Resources
AGE
51
TENURE
1.6 yrs
Board of Directors Tenure

Average tenure and age of the Inspire Medical Systems board of directors in years:

9.9
Average Tenure
58
Average Age
  • The tenure for the Inspire Medical Systems board of directors is about average.
Board of Directors

Marilyn Nelson

TITLE
Chair of the Board
COMPENSATION
$162K
AGE
78
TENURE
2.4 yrs

Timothy Herbert

TITLE
CEO, President & Director
COMPENSATION
$3M
AGE
55
TENURE
11.4 yrs

Joyce Erony

TITLE
Director
COMPENSATION
$143K
AGE
58
TENURE
2.4 yrs

Shawn McCormick

TITLE
Director
COMPENSATION
$150K
AGE
54
TENURE
2.3 yrs

Casey Tansey

TITLE
Director
COMPENSATION
$146K
AGE
60
TENURE
11.3 yrs

Chau Khuong

TITLE
Director
COMPENSATION
$141K
AGE
42
TENURE
5 yrs

Dana Mead

TITLE
Director
COMPENSATION
$143K
AGE
59
TENURE
10.8 yrs

Mudit Jain

TITLE
Director
COMPENSATION
$143K
AGE
49
TENURE
9.9 yrs

Jerry Griffin

TITLE
Director
COMPENSATION
$145K
AGE
73
TENURE
11.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
12. Apr 19 Sell GDN Holdings, LLC Company 10. Apr 19 10. Apr 19 -47,015 $55.21 $-2,595,698
12. Mar 19 Sell OrbiMed Advisors, L.L.C. Company 07. Mar 19 08. Mar 19 -358,449 $57.75 $-20,513,512
08. Mar 19 Sell U.S. Venture Partners Company 07. Mar 19 07. Mar 19 -25,000 $54.78 $-1,369,395
13. Dec 18 Sell OrbiMed Advisors, L.L.C. Company 11. Dec 18 11. Dec 18 -614,772 $37.60 $-23,115,427
13. Dec 18 Sell Jerry Griffin Individual 11. Dec 18 11. Dec 18 -1,300 $37.60 $-48,880
10. May 18 Buy Amzak Health Investors, Llc Company 07. May 18 07. May 18 125,000 $16.00 $2,000,000
10. May 18 Buy GDN Holdings, LLC Company 07. May 18 07. May 18 62,500 $16.00 $1,000,000
10. May 18 Buy OrbiMed Advisors, L.L.C. Company 07. May 18 07. May 18 312,500 $16.00 $5,000,000
10. May 18 Buy U.S. Venture Partners Company 07. May 18 07. May 18 187,500 $16.00 $3,000,000
10. May 18 Buy Shawn McCormick Individual 07. May 18 07. May 18 3,000 $16.00 $48,000
10. May 18 Buy Dana Mead Individual 07. May 18 07. May 18 20,000 $16.00 $320,000
10. May 18 Buy Timothy Herbert Individual 07. May 18 07. May 18 350 $16.00 $5,600
10. May 18 Buy Steven Jandrich Individual 07. May 18 07. May 18 2,050 $16.00 $32,800
10. May 18 Buy Richard Buchholz Individual 07. May 18 07. May 18 4,750 $16.00 $76,000
10. May 18 Buy Randy Ban Individual 07. May 18 07. May 18 900 $16.00 $14,400
X
Management checks
We assess Inspire Medical Systems's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Inspire Medical Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Have Insiders Been Buying Inspire Medical Systems, Inc. (NYSE:INSP) Shares?

So shareholders might well want to know whether insiders have been buying or selling shares in Inspire Medical Systems, Inc. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … Inspire Medical Systems Insider Transactions Over The Last Year.

Simply Wall St -

Could Inspire Medical Systems, Inc.'s (NYSE:INSP) Investor Composition Influence The Stock Price?

Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. … It has a market capitalization of US$947m, which means it would generally expect to see some institutions on the share registry. … institutions are noticeable on the share registry.

Simply Wall St -

Is Inspire Medical Systems Inc's (NYSE:INSP) Balance Sheet Strong Enough To Weather A Storm?

Inspire Medical Systems Inc (NYSE:INSP) is a small-cap stock with a market capitalization of US$880m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Evaluating financial health as part of your investment thesis is

Simply Wall St -

Interested In Inspire Medical Systems Inc (NYSE:INSP)? Here's How It Performed Recently

Understanding how Inspire Medical Systems Inc (NYSE:INSP) is performing as a company requires looking at more than just a years' earnings. … Today I will run you through a basic sense check to gain perspective on how Inspire Medical Systems is doing by comparing its latest earnings with its long-term trend as well as the performance of its healthcare services industry peers. … Check out our latest analysis for Inspire Medical Systems?

Simply Wall St -

Inspire Medical Systems Inc (NYSE:INSP): Is Breakeven Near?

Inspire Medical Systems Inc's (NYSE:INSP): Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). … Check out our latest analysis for Inspire Medical Systems Expectation from analysts is INSP is on the verge of breakeven. … Working backwards from analyst estimates, it turns out that they expect the company to grow 29.15% year-on-year, on average, which signals high confidence from analysts.

Simply Wall St -

Does Inspire Medical Systems Inc's (NYSE:INSP) Latest Financial Perfomance Look Strong?

Today I will run you through a basic sense check to gain perspective on how Inspire Medical Systems is doing by comparing its latest earnings with its long-term trend as well as the performance of its healthcare services industry peers. … See our latest analysis for Inspire Medical Systems Did INSP beat its long-term earnings growth trend and its industry? … NYSE:INSP Income Statement May 22nd 18 We can further examine Inspire Medical Systems's loss by looking at what the industry has been experiencing over the past few years.

Simply Wall St -

What does Inspire Medical Systems Inc's (NYSE:INSP) Balance Sheet Tell Us About Its Future?

Over the past year, INSP has maintained its debt levels at around US$16.46M – this includes both the current and long-term debt. … At this current level of debt, the current cash and short-term investment levels stands at US$16.14M for investing into the business. … Running high debt, while not yet making money, can be risky in unexpected downturns as liquidity may dry up, making it hard to operate.Next Steps: INSP’s debt and cash flow levels indicate room for improvement.

Simply Wall St -

Company Info

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

Details
Name: Inspire Medical Systems, Inc.
INSP
Exchange: NYSE
Founded: 2007
$1,284,531,002
23,457,469
Website: http://www.inspiresleep.com
Address: Inspire Medical Systems, Inc.
5500 Wayzata Boulevard,
Suite 1600,
Golden Valley,
Minnesota, 55416,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE INSP Common Stock New York Stock Exchange US USD 03. May 2018
DB 2DR Common Stock Deutsche Boerse AG DE EUR 03. May 2018
Number of employees
Current staff
Staff numbers
165
Inspire Medical Systems employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/17 01:15
End of day share price update: 2019/04/16 00:00
Last estimates confirmation: 2019/04/12
Last earnings filing: 2019/02/26
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.